ROCKVILLE, Md., July 31, 2019 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX), a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy ...
Pfizer is now leading the coronavirus vaccine race: The company announced Monday that people who received its two shots during the company's final stage of clinical trials were less likely to develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback